Core Scientific Inc (CORZ) Stock Analysis

Verdict: AVOID

Massive HPC power contracts with AMD and CoreWeave validate the AI pivot, but $4.30B in debt and negative equity create acute solvency risk.

Investment score: 34/100

Analysis as of

Is Core Scientific Inc stock worth reviewing? The TradeMates thesis

The model rates Core Scientific an AVOID due to high balance sheet leverage ($4.30B debt), negative total equity (-$2.42B), and heavy quarterly cash burn, despite impressive long-term HPC colocation contracts.

7-factor investment score

Core Scientific Inc opportunities and risks

What speaks for CORZ

What speaks against CORZ

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
CORZn/a11.9xn/a28.3%-325.9%-18.4%
TTANn/a6.0xn/a71.1%-12.1%2.0%
CIFRn/a33.1xn/a-20.0%-585.8%-23.7%
QBTSn/a489.5xn/a64.2%-2001.6%-2.0%
PEGA18.1x3.3x28.2x75.6%18.7%8.9%
ZETAn/a5.2x106.1x61.3%-0.1%2.8%
Peer mediann/a6.0xn/a64.2%-12.1%2.0%

Frequently asked questions about Core Scientific Inc (CORZ)

Is CORZ stock a good investment?

The TradeMates model rates Core Scientific Inc as AVOID with an investment score of 34/100. The model rates Core Scientific an AVOID due to high balance sheet leverage ($4.30B debt), negative total equity (-$2.42B), and heavy quarterly cash burn, despite impressive long-term HPC colocation contracts. This is algorithmic model output, not personal investment advice.

Is CORZ stock a buy?

The TradeMates model verdict for CORZ is AVOID with an investment score of 34/100. Treat this as a model signal to review, not a personal buy recommendation.